Guadalupe Hayes-Mota
Founder
HS
Healr Solutions
1/10Traction
Healr Solutions offers a technology platform that uses AI and deep supply chain expertise to optimize biotechnology drug production and distribution. Their Connected-Network™ technology enhances visibility and intelligence, accelerating treatment delivery and reducing pharmaceutical waste.
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Biotechnology supply chains face inefficiencies in drug production and distribution, leading to delays in patient access and increased product waste. The complexity of these networks often hinders real-time visibility and proactive management of critical logistics.
Solution
Healr Solutions provides a technology platform designed to enhance connectivity and intelligence within biotechnology supply chains. By integrating deep supply chain expertise with advanced Artificial Intelligence, the platform optimizes drug production and distribution processes. This results in accelerated delivery of treatments to patients globally and a significant reduction in pharmaceutical waste. The core of the offering is the Connected-Network™ technology, which aims to create more responsive and efficient supply chain operations.
Target Audience
Healr Solutions targets leading biotechnology companies seeking to improve the efficiency and speed of their drug production and distribution networks.
Features
- Connected-Network™ platform for enhanced supply chain visibility and orchestration.
- AI-driven analytics for optimizing drug production timelines.
- Predictive modeling to reduce waste in pharmaceutical distribution.
- Real-time data integration for improved logistics management.
- Focus on accelerating the delivery of biopharmaceutical treatments.